Protheragen 台灣代理商卓昇有限公司 交貨迅速 品質有保障 電話: 02-2736 7100
Protheragen是家經 ISO9001 認證的醫藥原料及特殊化學品供應商
Protheragen極力幫助客戶以經濟高效的方式提升研發效率。
我們的技術和科學研究團隊為全球工業產業提供可靠的產品和解決方案，包括化學產品、包裝和設備以及客製化合成。
憑藉先進的生產設施和專業的研發團隊，我們致力於成為業界領先企業，並且已經朝著這個目標邁進。
為什麼選擇我們?
品質管制:
我們建立嚴格的控制措施，確保每一件產品都符合客戶的要求。
客製化服務
無論您是生技公司還是製藥公司，我們都擁有與各類客戶合作的經驗。
專業團隊
我們擁有高素質的團隊，致力於實現我們的願景。
先進技術
我們採用尖端設備提供精準的分析服務，確保準確性和可靠性。
API 的重要性 :
藥物活性成分（API）是藥物發揮藥理作用的關鍵物質，直接決定了藥物的有效性和安全性。作為製藥產業鏈的核心環節，高純度、穩定的API是確保藥物一致性和生物利用度的基礎。在全球化監管日益嚴格、競爭激烈的製藥環境中，選擇優質的API供應商是製藥企業控制風險、加速註冊速度、提升市場競爭力的策略選擇。
我們的核心優勢
安全穩定的供應鏈
完整的合規文件（可提供DMF）
在GMP環境下生產
經濟高效
Protheragen 憑藉多年的經驗和卓越的技術，專門為全球製藥公司提供全系列高品質 API 產品，以支援其創新藥物開發或仿製藥製造。
我們的API產品廣泛應用於多個關鍵治療領域，涵蓋抗腫瘤、神經系統疾病、降血糖、代謝等方向，為全球製藥公司提供堅實的原料藥物支援。
我們在全球建有多個符合GMP標準的生產基地，配備先進的生產設備和嚴格的品質控制體系，確保每一款API產品都符合最高的國際標準。
以下是我們一些獲得廣泛認可和讚譽的暢銷API產品。
Protheragen提供符合國際標準的全系列API產品，用於治療神經系統疾病，廣泛應用於抗憂鬱、抗癲癇、神經退化性疾病等。
Protheragen的神經系統API產品涵蓋主流神經系統標靶，例如5-HT再攝取抑制劑（SSRIs）、多巴胺受體激動劑、GABA類似物、NMDA受體類似物、乙醯膽鹼酯酶抑制劑等。
More information visit : http://www.protheragen.ai
訂購Protheragen 專線請洽: 卓昇有限公司 (02)2736 7100 或 0800 088 700
我要詢價/訂貨
Product Name | CAS Number | Indication | Qualification | Standard | Related Drug Patent |
Aripiprazole | 129722-12-9 | Schizophrenia and bipolar I | USDMF/CEP | EP/USPFacility GMP | ABILIFY ASIMTUFII®ABILIFY MYCITE KIT®ABILIFY® |
Brexpiprazole | 913611-97-9 | Schizophrenia, major depressive disorder and Alzheimer’s disease | USDMF | In-houseFacility GMP | REXULTI® |
Lamotrigine | 84057-84-1 | Epilepsy and bipolar disorder | USDMF/CEP/Canadian DMF | EP/USPFacility GMP | LAMICTAL ODT® |
Desvenlafaxine Succinate | 386750-22-7 | Depression | USDMF | Facility GMP | PRISTIQ® |
Eslicarbazepine Acetate | 236395-14-5 | Adjunctive therapy for epilepsy | USDMF in processing | In-houseFacility GMP | APTIOM® |
Memantine Hydrochloride | 41100-52-1 | Severe dementia related to Alzheimer’s disease | USDMF/ASMF/PMDA | USPFacility GMP | NAMZARIC® |
Vutrisiran | 1867157-35-4 | Polyneuropathy | AMVUTTRA® | ||
Pimavanserin Tartrate | 706782-28-7 | Parkinson’s disease | NUPLAZID® |
Product Name | CAS Number | Indication | Qualification | Standard | Related Drug Patent |
Enzalutamide | 915087-33-1 | Prostate cancer | USDMF/ASMF | In-houseFacility GMP | XTANDI® |
Dacomitinib | 1110813-31-4 | Non-small cell lung cancer | USDMF | Facility GMP | VIZIMPRO® |
Olaparib | 763113-22-0 | Ovarian, breast and prostate cancer | USDMF/ASMF | USPFacility GMP | LYNPARZA® |
Idelalisib | 870281-82-6 | Leukemia and cellular lymphoma | USDMF | Facility GMP | ZYDELIG® |
Carfilzomib | 868540-17-4 | Multiple myeloma | USDMF | In-houseFacility GMP | KYPROLIS® |
Bendamustine Hydrochloride Monohydrate | 1374784-02-7 | Chronic lymphocytic leukemia and lymphoma | ASMF/Canada-HC | Facility GMPProduct GMP | TREANDA® |
Lenalidomide | 191732-72-6 | Multiple myeloma | USDMF/ASMF | In-houseFacility GMP | REVLIMID® |
Cabazitaxel | 183133-96-2 | Prostate cancer | USDMF/EMA | In-houseFacility GMP | JEVTANA KIT® |
Afatinib Dimaleate | 850140-73-7 | Non-small cell lung cancer | USDMF/ASMF | Facility GMP | GILOTRIF® |
Ponatinib HCl | 1114544-31-8 | Chronic myeloid leukemia | USDMF/HC MF | Facility GMP | ICLUSIG® |
Dasatinib | 302962-49-8 | Chronic myeloid leukemia | Facility GMP | SPRYCEL® | |
Nilotinib HCl | 923288-95-3 | Chronic myeloid leukemia | USDMF/CEP/EMA | EP/USPFacility GMP | TASIGNA® |
Daunorubicin HCl | 23541-50-6 | Acute myelogenous leukemia, acute lymphoblastic leukemia and chronic myelogenous leukemia | USPFacility GMPProduct GMP | VYXEOS® | |
Sorafenib Tosylate | 475207-59-1 | Liver cancer, renal cell carcinoma, and differentiated thyroid carcinoma | ASMF/CEP/USDMF | Facility GMP | NEXAVAR® |
Ruxolitinib Phosphate | 1092939-17-7 | Intermediate or high-risk myelofibrosis | USDMF | In-houseFacility GMP | JAKAFI® |
Product Name | CAS Number | Indication | Qualification | Standard | Related Drug Patent |
Oxytocin | 24346-32-5 | Medical induced abortion | USDMF | GMP | OXYTOCIN® |
Vasopressin | 11000-17-2 | Increase blood pressure | USDMF | GMP | VASOPRESSIN® |
Parathyroid Hormone | 12584-96-2 | Hypoparathyroidism | USDMF | GMP | NATPARA® |
Octreotide Acetate | 760176-26-9 | Long-term maintenance treatment in acromegaly | USDMF | GMP | MYCAPSSA® |
Atosiban Acetate | 914453-95-5 | Contraction inhibitor | USDMF | GMP | TRACTOCILE® |
Cetrorelix Acetate | 120287-85-6 | Controlling ovulation | USDMF | GMP | CETROTIDE® |
Eptifibatide | 188627-80-7 | Anti-platelet aggregation | USDMF | GMP | EPTIFIBATIDE® |
Ganirelix Acetate | 123246-29-7 | Reduce estrogen | USDMF | GMP | GANIRELIX ACETATE® |
Thymalfasin | 69440-99-9 | Chronic hepatitis B | USDMF | GMP | |
Etelcalcetide | 1262780-97-1 | Chronic kidney diseases | USDMF | GMP | PARSABIV® |
Somatostatin | 38916-34-6 | Varicose veins bleeding, gastric bleeding, etc. | USDMF | GMP | STILAMIN® |
Terlipressin Acetate | 14636-12-5 | Improve liver and kidney functions | USDMF | GMP | TERLIVAZ® |
Plecanatide | 467426-54-6 | Adult CIC | USDMF | GMP | TRULANCE® |
Nirmatrelvir | 2628280-40-8 | COVID-19 | USDMF | GMP | PAXLOVID (COPACKAGED)® |
Ritonavir | 155213-67-5 | HIV | USDMF | GMP | NORVIR® |
Melphalan Flufenamide | 380449-54-7 | Multiple myeloma | USDMF | GMP | IVRA® |
Afamelanotide | 75921-69-6 | Darken the skin | USDMF | GMP | SCENESSE® |
Carbetocin | 37025-55-1 | Uterine contraction | USDMF | GMP | CARBETOCIN INJECTION® |
Voclosporin | 515814-01-4 | Lupus nephritis | USDMF | GMP | LUPKYNIS® |
Ivosidenib | 1448347-49-6 | Acute myelogenous leukemia | USDMF | GMP | TIBSOVO® |
Abaloparatide | 247062-33-5 | Osteoporosis in postmenopausal women | USDMF | GMP | TYMLOS® |
Angiotensin II | 4474-91-3 | Traumatic or post-operative shock and hypotension caused by general or lumbar anesthesia | USDMF | GMP | GIAPREZA® |
Terlipressin | 14636-12-5 | Improve liver and kidney functions | USDMF | GMP | TERLIVAZ® |
Teriparatide | 52232-67-4 | Osteoporosis | USDMF | TERLIVAZ® | |
Lixisenatide | 320367-13-3 | Diabetes | LYXUMIA® | ||
Grazoprevir | 1350514-68-9 | Hepatitis C | ZEPATIER® | ||
Oritavancin | 171099-57-3 | Adult ABSSSI | KIMYRSA® | ||
Macimorelin | 381231-18-1 | AGHD and CACS | MACRILEN® | ||
Dulaglutide | 923950-08-7 | Type II diabetes | TRULICITY® | ||
Albiglutide | 782500-75-8 | Type II diabetes | TANZEUM® | ||
Dalbavancin | 171500-79-1 | Skin and soft tissue infection | USDMF | DALVANCE® | |
Voxilaprevir | 1535212-07-7 | HCV infection | VOSEVI® | ||
Difelikefalin | 1024828-77-0 | Moderate to severe pruritus | USDMF | KORSUVA® |